Showing results (181-190 of 234) with videos related to
Sort By:
Pageof 24
Cancer Chemotherapy and Pharmacology|April 24, 2013
Analysis of the potential effect of ponatinib on the QTc interval in patients with refractory hematological malignanciesDaryl Sonnichsen, David J Dorer, Jorge Cortes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidinesHeinz-Josef Lenz, Eric Van Cutsem, Shirin Khambata-Ford, et al.Biorxiv : the Preprint Server for Biology|February 23, 2026
Repeat expansions in C9orf72 rewire the 3D chromatin landscape in ALSTatiana Ulloa Avila, Jingying Wang, Lydia Adams, et al.Cancer Research|October 24, 2018
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in LeukemiaDavid R Spiciarich, Stephen T Oh, Amy Foley, et al.Journal of Cancer Research and Clinical Oncology|April 17, 2019
Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemiaJorge E Cortes, Carlo Gambacorti-Passerini, Michael W Deininger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximabGeorg Lurje, Fumio Nagashima, Wu Zhang, et al.Health Physics|November 1, 1996
Technical basis for EPA's proposed regulation on the cleanup of sites contaminated with radioactivityA B Wolbarst, J Mauro, R Anigstein, et al.Nature|September 3, 2013
Topoisomerases facilitate transcription of long genes linked to autismIan F King, Chandri N Yandava, Angela M Mabb, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2010
A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapyW Zhang, T Winder, Y Ning, et al.British Journal of Haematology|May 29, 2023
Treatment-free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5-year analysis of DASFREENeil P Shah, Valentín García-Gutiérrez, Antonio Jiménez-Velasco, et al.Pageof 24